
US Nuclear Corp., together with its subsidiaries, engages in the developing, manufacturing, and selling radiation detection and measuring equipment worldwide. It operates through two segments, Optron and Overhoff. The company offers radiation water monitors that allow the detection of radioactive materials in drinking water, ground water, rainfall, rivers, and lakes; alpha, beta, gamma, and neutron monitors; DroneRAD aerial radiation detection; air and water monitors; and nano-second X-ray monitors. It also provides vehicle, personnel, exit, and room monitors; radon air monitors and radon switch products to determine the radon content in the air in basements, mills, mines, and buildings; handheld survey meters, as well as personal dosimeters and pocket micro-R meters; and port security equipment. In addition, the company offers software, which measures gamma and neutron radiation levels; airborne radioactivity levels; temperature and humidity in the facility; status of security doors; wind speed and direction; and barometric pressure. Its products and services are used in nuclear reactor plants, universities, local and state hospitals, government agencies, and emergency medical technicians/first responders, as well as in airports, cargo, screening as ports and borders, and other critical infrastructure. The company is headquartered in Canoga Park, California.
US Nuclear Corp. trades as UCLE on OTC. The company is classified in Technology / Hardware, Equipment & Parts and reports in USD.
The current profile places the business in Hardware, Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $2.19M of revenue and -$1.74M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
US Nuclear Corp. can be compared against peers such as American Aires Inc., Cytta Corp., QuantGate Systems Inc., Remote Dynamics, Inc., Scientific Industries, Inc., VigilAigent Corp..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $2.46M, beta of -2.02, and return on equity of +203.2%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
UCLE currently shows total debt of $1.78M and beta of -2.02. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
Recent filings to review: NT 10-Q (2026-05-14 00:00:00), 8-K (2026-04-22 00:00:00), NT 10-K (2026-03-31 00:00:00), 10-Q (2026-01-27 00:00:00).
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://usnuclearcorp.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.